Chronic ventricular electrograms: do steroid-eluting leads differ from conventional leads?

Pacing Clin Electrophysiol. 1990 Dec;13(12 Pt 2):1879-82. doi: 10.1111/j.1540-8159.1990.tb06908.x.

Abstract

The aim of steroid-eluting leads is to reduce chronic pacing thresholds. Whether steroid-eluting leads also modify acute and chronic R wave amplitudes as well as R wave sensing of the pulse generator was investigated in 31 patients with a unipolar ventricular pacemaker. Four different leads were implanted: Two steroid-eluting leads with different electrode surface areas (8 mm2 and 5.8 mm2) and two conventional leads (Target Tip, Elgiloy lead). At implantation filtered R wave amplitudes, peak-to-peak values, and slew rates were measured by a pacing system analyzer. One year after implantation R wave amplitudes were directly determined from intracardiac electrograms and compared to the peak-to-peak data at implantation. Additionally, R wave inhibition was evaluated at a sensitivity setting of 5 mV. There were no differences among the four leads in respect to any of the parameters studied at implantation. At follow-up, no differences in R wave amplitudes were found leading to an appropriate sensing in all leads. Steroid-eluting leads did not differ from conventional leads and a smaller electrode surface area of 5.8 mm2 had no influence on ventricular electrogram. Together with a pacemaker with an input impedance of 37 kohms R wave sensing was a correct setting of 5 mV.

MeSH terms

  • Aged
  • Alloys
  • Dexamethasone / administration & dosage*
  • Drug Implants
  • Electric Conductivity
  • Electrocardiography*
  • Electrodes, Implanted*
  • Equipment Design
  • Female
  • Gold Alloys
  • Heart Ventricles
  • Humans
  • Iridium
  • Male
  • Pacemaker, Artificial*
  • Platinum
  • Silicones
  • Surface Properties
  • Time Factors
  • Titanium

Substances

  • Alloys
  • Drug Implants
  • Gold Alloys
  • Silicones
  • Iridium
  • Platinum
  • Dexamethasone
  • Titanium